# Rebecca Grainger

Rebecca Grainger is a New Zealand academic rheumatologist, and is a full professor at the University of Otago, specialising in rheumatoid arthritis and osteoarthritis, and gout. She is also interested in the use of technology for medical education and digital health.

## Academic career

Grainger completed a Bachelor of Medicine and a PhD titled Systemic soluble and cellular mediators of gouty arthritis: a comparative observational study at the University of Otago, based in the Malaghan Institute. She received further rheumatology training in Melbourne. Grainger practised as a rheumatologist, and joined the faculty of the University of Otago in Wellington 2008, rising to full professor in 2022. She is a consultant rheumatologist at Hutt District Health Board.
Grainger's research focuses on arthritis and other inflammatory conditions, but she is also interested in digital health and medical education using technology. She is on the steering committee of the COVID-19 Global Rheumatology Alliance, which delivers accurate and evidence-based information for rheumatology providers and patients. Grainger has held leadership roles in Arthritis New Zealand (2014–2018), the New Zealand Rheumatology Association, the Royal Australasian College of Physicians, and the American College of Rheumatology. She has been a member of the Research Advisory Committee for Research for Life, also known as the Wellington Medical Research Foundation, since 2012, and was appointed chair in 2018. Grainger has been an associate editor of Focus on Health Professional Education since 2023.

## Honours and awards

Grainger was elected a Fellow of the International Academy of Health Sciences Informatics in 2018/19, and as a Fellow of Health Informatics New Zealand in 2021.

## Selected works

* Stephen S Lim; Theo Vos; Abraham D Flaxman; et al. (1 December 2012). "A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010". The Lancet. 380 (9859): 2224–2260. doi:10.1016/S0140-6736(12)61766-8. ISSN 0140-6736. PMC 4156511. PMID 23245609. Wikidata Q27860879.
* Christopher J L Murray; Rafael Lozano; Mohsen Naghavi; et al. (15 December 2012). "Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010". The Lancet. 380 (9859): 2197–223. doi:10.1016/S0140-6736(12)61689-4. ISSN 0140-6736. PMID 23245608. Wikidata Q27860791.
* Theo Vos; Abraham D Flaxman; Mohsen Naghavi; et al. (15 December 2012). "Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010". The Lancet. 380 (9859): 2163–2196. doi:10.1016/S0140-6736(12)61729-2. ISSN 0140-6736. PMC 6350784. PMID 23245607. Wikidata Q28111913.
* Milena Gianfrancesco; Kimme L Hyrich; Sarah Al-Adely; et al. (29 May 2020). "Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry". Annals of the Rheumatic Diseases. 79 (7): 859–866. doi:10.1136/ANNRHEUMDIS-2020-217871. ISSN 0003-4967. PMC 7299648. PMID 32471903. Wikidata Q96022237.{{cite journal}}: CS1 maint: numeric names: authors list (link)
* Qian Liu; Susan Geertshuis; Rebecca Grainger (July 2020). "Understanding academics' adoption of learning technologies: A systematic review". Computers and Education. 151: 103857. doi:10.1016/J.COMPEDU.2020.103857. ISSN 0360-1315. Wikidata Q125251070.
* Rebecca Grainger; Hermaleigh Townsley; Bonnie White; Tobias Langlotz; William J Taylor (21 February 2017). "Apps for People With Rheumatoid Arthritis to Monitor Their Disease Activity: A Review of Apps for Best Practice and Quality". JMIR mHealth and uHealth. 5 (2): e7. doi:10.2196/MHEALTH.6956. ISSN 2291-5222. PMC 5340922. PMID 28223263. Wikidata Q33452891.
* Rebecca Grainger; Alfred H J Kim; Richard Conway; Jinoos Yazdany; Philip C Robinson (April 2022). "COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations". Nature Reviews Rheumatology. 18 (4): 191–204. doi:10.1038/S41584-022-00755-X. ISSN 1759-4790. PMC 8874732. PMID 35217850. Wikidata Q125185556.